EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Edwards Lifesciences Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026

$87.22+0.62 (+0.72%)

Close on Oct 19, 2026

Community

Notes and questions about Edwards Lifesciences from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Edwards Lifesciences's annual and quarterly filings with the SEC
Per-share figures adjusted for the 3-for-1 split on Jun 1, 2020
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is EW.

Revenue growth14.6% · median 6.9%

Gross margin77.8% · median 52.8%

Operating margin22.3% · median 8.3%

Net margin15.4% · median 2.0%

Advertisement
300 × 250